TCGC 2015 | Breast Cancer Genomics, Predictive Data and Therapy Guidance

Laura J. van ’t Veer of University of California, San Francisco speaks to CHI on March 4, 2015. Dr. van ‘t Veer will be a keynote presenter at TCGC: The Clinical Genome Conference, June 22-24 in San Francisco, CA. Topics include the genetic makeup of breast cancer tumors and personalized medicine; transdisciplinary research collaborations related to the MammaPrint test; molecular genomic data integration, cancer patient therapy and survival prediction. For more information visit http://www.ClinicalGenomeConference.com/